www.newswire.ca/en/releases/archive/July2008/02/c9402.h -
[Cached Version]
Published on: 7/3/2008
Last Visited: 7/3/2008
Canada," said Barry D. Stein, president of the Colorectal Cancer Association of Canada. Ontario joins British Columbia, Saskatchewan, Quebec, Newfoundland, and Nova Scotia in providing public reimbursement of Avastin."This means that thousands of first-line metastatic colorectal cancer patients in Ontario will be offered Avastin, an innovative biologic medication which prolongs life in patients, and for some may offer a cure when coupled with surgery," Stein added. Concerning the Ontario government's additional announcement today that it intends to require the K-ras mutation test, a test that indicates which patients are more likely to benefit from certain treatments, namely Vectibix and Erbitux, the CCAC hopes the province will provide its funding."This is an important test and will provide patients with the opportunity for tailor-made treatments," said Stein.
...
colorectal cancer would still be alive today," said Stein.
...
For further information: or to schedule an interview with a patient or physician, contact: Barry Stein, president, (514) 944-0200; or Hilary Christo,